Sign In
Buy BEAT
$0.710
-0.0495 (-6.52%)
At Close: Jun 22, 2026
BIOTELEMETRY, INC. EXPANDS MCOT™ SERVICE TO MONITOR LIFE-THREATENING QT PROLONGATION IN COVID-19 PATIENTS
01:21pm, Wednesday, 25'th Mar 2020
Only remote cardiac monitoring company whose proprietary connected system has FDA-approved indication to measure, analyze and report QT interval
Global Cardiovascular Disease Monitoring and Diagnostic Devices Market Forecast to Grow by US$1.2 Billion, Driven by a CAGR of 7%
02:00pm, Tuesday, 24'th Mar 2020
The "Cardiovascular Disease Monitoring and Diagnostic Devices - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
BioTelemetry Inc (NASDAQ:BEAT) Stake Lessened by Raymond James & Associates
10:14am, Monday, 23'rd Mar 2020
Raymond James & Associates cut its stake in BioTelemetry Inc (NASDAQ:BEAT) by 7.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). T
BioTelemetry (NASDAQ:BEAT) Price Target Lowered to $55.00 at Benchmark
05:22am, Monday, 23'rd Mar 2020
BioTelemetry (NASDAQ:BEAT) had its price target decreased by Benchmark from $82.00 to $55.00 in a research report released on Thursday, BenzingaRatingsTable reports. Benchmark currently has a buy rati
BioTelemetry Inc (NASDAQ:BEAT) Expected to Post Earnings of $0.44 Per Share
09:58am, Sunday, 22'nd Mar 2020
Analysts forecast that BioTelemetry Inc (NASDAQ:BEAT) will post $0.44 earnings per share for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for BioTelemet
Brokerages Expect BioTelemetry Inc (NASDAQ:BEAT) Will Announce Quarterly Sales of $114.42 Million
07:44am, Saturday, 21'st Mar 2020
Brokerages expect that BioTelemetry Inc (NASDAQ:BEAT) will announce $114.42 million in sales for the current fiscal quarter, Zacks reports. Three analysts have made estimates for BioTelemetry’s earn
How Does BioTelemetry’s (NASDAQ:BEAT) P/E Compare To Its Industry, After The Share Price Drop?
12:58pm, Friday, 20'th Mar 2020
To the annoyance of some shareholders, BioTelemetry (NASDAQ:BEAT) shares are down a considerable 41% in the last...
Envestnet Asset Management Inc. Raises Stake in BioTelemetry Inc (NASDAQ:BEAT)
10:04am, Friday, 20'th Mar 2020
Envestnet Asset Management Inc. boosted its position in BioTelemetry Inc (NASDAQ:BEAT) by 21.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities &
BioTelemetry Inc (NASDAQ:BEAT) Shares Purchased by Bank of Montreal Can
09:32am, Friday, 20'th Mar 2020
Bank of Montreal Can lifted its position in BioTelemetry Inc (NASDAQ:BEAT) by 58.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commiss
Ancora Advisors LLC Boosts Stake in BioTelemetry Inc (NASDAQ:BEAT)
08:38am, Friday, 20'th Mar 2020
Ancora Advisors LLC grew its stake in shares of BioTelemetry Inc (NASDAQ:BEAT) by 7.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional in
BioTelemetry (NASDAQ:BEAT) Rating Lowered to Sell at BidaskClub
07:48am, Friday, 20'th Mar 2020
BioTelemetry (NASDAQ:BEAT) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a note issued to investors on Friday, BidAskClub reports. Other equities an
Benchmark Maintains Buy on BioTelemetry, Lowers Price Target to $55
01:18pm, Thursday, 19'th Mar 2020We Think BioTelemetry (NASDAQ:BEAT) Can Stay On Top Of Its Debt
12:29pm, Thursday, 19'th Mar 2020
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
11:37am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) * Biomerica, Inc. (NASDAQ: BMRA)( announced comm
Great West Life Assurance Co. Can Makes New $1.87 Million Investment in BioTelemetry Inc (NASDAQ:BEAT)
09:54am, Thursday, 19'th Mar 2020
Great West Life Assurance Co. Can bought a new position in BioTelemetry Inc (NASDAQ:BEAT) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SE
